4.6 Article

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Tropical Medicine

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)

Anjan Debnath et al.

PLoS Neglected Tropical Diseases (2017)

Article Public, Environmental & Occupational Health

Primary Amebic Meningoencephalitis Associated with Exposure to Swimming Pool Water Supplied by an Overland Pipe - Inyo County, California, 2015

Richard O. Johnson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)

Article Cell Biology

A small-molecule antivirulence agent for treating Clostridium difficile infection

Kristina Oresic Bender et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Microbiology

Identification of Peptidases in Highly Pathogenic vs. Weakly Pathogenic Naegleria fowleri Amebae

Ishan K. Vyas et al.

JOURNAL OF EUKARYOTIC MICROBIOLOGY (2015)

Article Critical Care Medicine

Activation of NF-κB Mediates Astrocyte Swelling and Brain Edema in Traumatic Brain Injury

Arumugam R. Jayakumar et al.

JOURNAL OF NEUROTRAUMA (2014)

Review Public, Environmental & Occupational Health

Military Aircrew and Noise-Induced Hearing Loss: Prevention and Management

Renu Rajguru

AVIATION SPACE AND ENVIRONMENTAL MEDICINE (2013)

Article Microbiology

Corifungin, a New Drug Lead against Naegleria, Identified from a High-Throughput Screen

Anjan Debnath et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Article Critical Care Medicine

A rare case of survival from primary amebic meningoencephalitis

Parshotam Lal Gautam et al.

INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2012)

Article Chemistry, Multidisciplinary

Synthesis, Structure, and Glutathione Peroxidase-Like Activity of Amino Acid Containing Ebselen Analogues and Diaryl Diselenides

Karuthapandi Selvakumar et al.

CHEMISTRY-A EUROPEAN JOURNAL (2011)

Review Infectious Diseases

Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri

Johan F. De Jonckheere

INFECTION GENETICS AND EVOLUTION (2011)

Article Immunology

Primary Amebic Meningoencephalitis Caused by Naegleria fowleri, Karachi, Pakistan

Sadia Shakoor et al.

EMERGING INFECTIOUS DISEASES (2011)

Review Infectious Diseases

Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment

Govinda S. Visvesvara

CURRENT OPINION IN INFECTIOUS DISEASES (2010)

Article Public, Environmental & Occupational Health

The epidemiology of primary amoebic meningoencephalitis in the USA, 1962-2008

J. S. Yoder et al.

EPIDEMIOLOGY AND INFECTION (2010)

Article Biochemistry & Molecular Biology

Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome

Christine Juliana et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Chemistry, Multidisciplinary

Amide-Based Glutathione Peroxidase Mimics: Effect of Secondary and Tertiary Amide Substituents on Antioxidant Activity

Krishna P. Bhabak et al.

CHEMISTRY-AN ASIAN JOURNAL (2009)

Article Parasitology

Characterization of brain inflammation during primary amoebic meningoencephalitis

Isaac Cervantes-Sandoval et al.

PARASITOLOGY INTERNATIONAL (2008)

Review Biochemistry & Molecular Biology

Drug discovery and development for neglected parasitic diseases

Adam R. Renslo et al.

NATURE CHEMICAL BIOLOGY (2006)

Article Medicine, Research & Experimental

Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous Amphotericin B, Fluconazole and rifampicin

J Vargas-Zepeda et al.

ARCHIVES OF MEDICAL RESEARCH (2005)

Review Pharmacology & Pharmacy

Opportunistic amoebae: challenges in prophylaxis and treatment

FL Schuster et al.

DRUG RESISTANCE UPDATES (2004)

Article Pharmacology & Pharmacy

Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia

JB Salom et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2004)

Article Pharmacology & Pharmacy

Ebselen: prospective therapy for cerebral ischaemia

M Parnham et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)